DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX) announced today that it will present at the UBS Global Life Sciences Conference on Wednesday, September 21, at 7:30 a.m. (CT) or 8:30 a.m. (ET).
The live webcast of Baxter’s presentation can be accessed from the Baxter corporate website at www.baxter.com and will be available for replay through October 22, 2011.
Baxter International Inc. develops, manufactures and markets products that save and sustain the lives of people with hemophilia, immune disorders, infectious diseases, kidney disease, trauma, and other chronic and acute medical conditions. As a global, diversified healthcare company, Baxter applies a unique combination of expertise in medical devices, pharmaceuticals and biotechnology to create products that advance patient care worldwide.
CONTACT:
Baxter International Inc.
Media Contact:
Deborah Spak, (847) 948-2349
or
Investor Contacts:
Mary Kay Ladone, (847) 948-3371
Clare Trachtman, (847) 948-3085
KEYWORDS: United States North America Illinois
INDUSTRY KEYWORDS: Health Biotechnology Hospitals Medical Devices Pharmaceutical Medical Supplies General Health
MEDIA:
| Logo |